Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials. (Record no. 29663181)

MARC details
000 -LEADER
fixed length control field 01712 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518035943.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202008s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2152-2669
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.clml.2019.04.003
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mushtaq, Adeela
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200804
245 00 - TITLE STATEMENT
Title Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical lymphoma, myeloma & leukemia
Date of publication, distribution, etc. 07 2019
300 ## - PHYSICAL DESCRIPTION
Extent 447-461 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Meta-Analysis; Systematic Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase II as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase III as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Myeloma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recurrence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retreatment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thalidomide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Iftikhar, Ahmad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hassan, Hamza
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lakhani, Midhat
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sagar, Fnu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kamal, Ahmad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zahid, Umar
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ali, Zeeshan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Razzaq, Faryal
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zar, Muhammad Abu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hassan, Syeda Fatima
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Safdar, Ahmad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raychaudhuri, Sreejata
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anwer, Faiz
773 0# - HOST ITEM ENTRY
Title Clinical lymphoma, myeloma & leukemia
Related parts vol. 19
-- no. 7
-- p. 447-461
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.clml.2019.04.003">https://doi.org/10.1016/j.clml.2019.04.003</a>
Public note Available from publisher's website

No items available.